JAMES T LAFRANCE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES T LAFRANCE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES T LAFRANCE. JAMES T LAFRANCE is Director in VERMILLION, INC. ($VRML) and Director in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM).
Latest Insider Trading Transactions of JAMES T LAFRANCE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | VRML | Aspira Women's Hea ... | LAFRANCE JAMES T | Director | Option Exercise | A | 7.40 | 15,412 | 114,049 | 15,412 | |
| Mar 23 2021 | VRML | Aspira Women's Hea ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 9,205 | 0 | 422,439 | 413.2 K to 422.4 K (+2.23 %) |
| Aug 21 2020 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 0.46 | 60,000 | 27,600 | 60,000 | |
| Jun 04 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Option Exercise | X | 1.80 | 5,210 | 9,378 | 0 | |
| Jun 04 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Buy | X | 1.80 | 5,210 | 9,378 | 434,480 | 429.3 K to 434.5 K (+1.21 %) |
| Jun 04 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Option Exercise | X | 1.80 | 5,210 | 9,378 | 0 | |
| Jun 04 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Buy | X | 1.80 | 5,210 | 9,378 | 434,480 | 429.3 K to 434.5 K (+1.21 %) |
| Mar 23 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Option Exercise | A | 0.68 | 147,783 | 100,492 | 147,783 | |
| Mar 23 2020 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 84,986 | 0 | 429,459 | 344.5 K to 429.5 K (+24.67 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 1.04 | 10,000 | 10,400 | 10,000 | |
| Aug 16 2019 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 12,500 | 10 K to 12.5 K (+25.00 %) |
| Mar 28 2019 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Option Exercise | A | 1.29 | 119,284 | 153,876 | 119,284 | |
| Mar 28 2019 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 45,455 | 0 | 343,473 | 298 K to 343.5 K (+15.25 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.54 | 2,900 | 1,566 | 298,018 | 300.9 K to 298 K (-0.96 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.54 | 2,900 | 1,566 | 298,018 | 300.9 K to 298 K (-0.96 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.51 | 7,500 | 3,825 | 300,918 | 308.4 K to 300.9 K (-2.43 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.51 | 7,500 | 3,825 | 300,918 | 308.4 K to 300.9 K (-2.43 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.49 | 10,427 | 5,109 | 301,418 | 311.8 K to 301.4 K (-3.34 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.49 | 10,427 | 5,109 | 301,418 | 311.8 K to 301.4 K (-3.34 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.51 | 2,573 | 1,312 | 318,845 | 321.4 K to 318.8 K (-0.80 %) |
| Aug 21 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Sell | S | 0.51 | 2,573 | 1,312 | 318,845 | 321.4 K to 318.8 K (-0.80 %) |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 3.31 | 10,000 | 33,100 | 10,000 | |
| Aug 17 2018 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Apr 17 2018 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 96,000 | 0 | 321,418 | 225.4 K to 321.4 K (+42.59 %) |
| Aug 24 2017 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Grant | A | 2.05 | 7,500 | 15,375 | 7,500 | 0 to 7.5 K |
| Aug 16 2017 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 2.27 | 6,000 | 13,620 | 6,000 | |
| Mar 27 2017 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 35,324 | 0 | 225,418 | 190.1 K to 225.4 K (+18.58 %) |
| Feb 15 2017 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Option Exercise | P | 1.80 | 5,021 | 9,038 | 5,021 | |
| Feb 15 2017 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Buy | P | 1.40 | 6,695 | 9,373 | 190,094 | 183.4 K to 190.1 K (+3.65 %) |
| Aug 30 2016 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 2.46 | 5,000 | 12,300 | 5,000 | |
| Aug 29 2016 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 2.61 | 6,000 | 15,660 | 6,000 | |
| Mar 21 2016 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 49,545 | 0 | 183,399 | 133.9 K to 183.4 K (+37.01 %) |
| Dec 02 2015 | HTGM | HTG MOLECULAR DIAG ... | LAFRANCE JAMES T | Director | Option Exercise | A | 4.88 | 5,000 | 24,400 | 5,000 | |
| Jul 15 2015 | VRML | VERMILLION, INC. | LAFRANCE JAMES T | Director | Grant | A | 0.00 | 39,330 | 0 | 133,854 | 94.5 K to 133.9 K (+41.61 %) |
Page: 1